Analyst
Lake Street
Equibles does not estimate personal net worth.
Thomas Flatton is recorded as Analyst at Lake Street. Thomas Flatton has spoken on 10 earnings calls across 7 companies, most recently for Journey Medical Corp on August 12, 2026. Those appearances were for Insight Molecular Diagnostics Inc. (IMDX), Aytu Biopharma, Inc (AYTU), Journey Medical Corp (DERM), Castle Biosciences Inc (CSTL), Biodesix Inc (BDSX) and 2 other companies. The companies whose calls Thomas Flatton spoke on are classified in the Healthcare sector.
“Claude, with respect to the new reps that were hired, can I assume those were white space hires, or are you already territory splitting?”
“Hey, Ryan, just doing some back-of-the-envelope math, I kind of figured about a million and a half in quote-unquote stocking revenue in the Exua number for that quarter.”
“I think you guys were relocating to a new Phoenix lab at some point this year. Any update on what impact that might have on gross margins going forward?”
“Just a question to follow up on the PCPs. I'm just curious what you're hearing anecdotally from the PCPs, their level of comfort at retaining these patients with this test result in hand.”
“So if you have 37 centers in the U.S. that are engaged, that you're engaged with, but 28 of them want to participate in the registry study, what does participation in the registry study mean from a revenue perspective?”
Lake Street
Analyst
Transcript header (unverified)
Diagnostics & Research · Healthcare
AYTU
Drug Manufacturers - Specialty & Generic · Healthcare
DERM
Drug Manufacturers - Specialty & Generic · Healthcare
BDSX
Diagnostics & Research · Healthcare
Assertio Holdings, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
Assertio Holdings, Inc. Q2 FY2025 Earnings Call
Assertio Holdings, Inc.
